• Barts MS Blog,  Monthly MS News,  MS,  Multiple Sclerosis

    MS News: March 2015

    Yes, here’s the March edition already! I will try and update the post each week as it will be a busy month ahead with Brain Awareness Week in Ireland, National MS Education and Awareness Month is an effort by the Multiple Sclerosis Foundation (MSF) and the US National Multiple Sclerosis Society’s MS Awareness Week. The big news this week is/has been all about coffee. According to the American Academy of Neurology, drinking coffee may be associated with a lower risk of developing multiple sclerosis (MS). Coffee intake may protect against MS, supporting the idea that the drug may have protective effects for the brain,” said study author Ellen Mowry, MD, MCR, with Johns Hopkins University School of Medicine in Baltimore and a member of the American Academy of Neurology. While…

  • MS,  Multiple Sclerosis,  Recommended,  Resources

    Clinical trials explained

      In the UK, it takes over 12 years to develop a new medicine to the standards of quality, efficacy and safety laid down by legislation. It typically costs £1.15 billion to do all the research and development necessary before a new medicine can be licensed for use. The majority of medicines under development never make it to the market; following thorough studies, they may be found to have unacceptable side effects, or they don’t work any better than existing treatments. Timeline of medicine development For every marketed medicine that makes enough money to pay for its development, about 25,000 chemical compounds were tested, on average 25 of these will have gone into clinical trials and five received approval for marketing. Our timeline of medicine development shows the stages a…

  • Barts MS Blog,  Monthly MS News,  MS,  Multiple Sclerosis

    MS News: February 2015

    Time flies, as we’re once again nearing the end of February. It’s been an attention-grabbing month, with several positive news stories about treatment and also, about a rather interesting collaboration between Google and Biogen Idec. First of all though, I wanted to add a link displaying how many clinical trials are ongoing as we speak. So dig in, and feel a little bit happier knowing that each day, a lot of people are seeking and working towards better treatment. Additionally, I added two new categories to the list, news about MS Organisations and Diet also. Highlight! Data Visualization Displays 142 Ongoing MS Clinical Trials MURDOCK study confirms Google partnership Google, Biogen Seek Reasons for Advance of Multiple Sclerosis Google Inc (GOOG) And Biogen Idec Inc Join Hands For Multiple Sclerosis…